172. 低ホスファターゼ症 Hypophosphatasia Clinical trials / Disease details
臨床試験数 : 34 / 薬物数 : 19 - (DrugBank : 4) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 6
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04181164 (ClinicalTrials.gov) | October 1, 2019 | 18/11/2019 | Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP) | Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP) | Hypophosphatasia (HPP) | Other: Microindentation;Other: High resolution peripheral quantitative computed tomography (HRpQCT);Biological: Biochemical analysis of different bone markers. | Hvidovre University Hospital | Odense University Hospital | Active, not recruiting | 18 Years | N/A | All | 30 | Denmark |